The molecular basis for the lack of inflammatory responses in mouse embryonic stem cells and their differentiated cells

Journal of Immunology

Volumn 198, Issue 5, 2017, Pages 2147-2155

  D'Angelo, William ^a   Gurung, Chandan ^a   Acharya, Dhiraj ^a   Chen, Bohan ^a   Ortolano, Natalya ^b   Gama, Vivian ^b   Bai, Fengwei ^a   Guo, Yan Lin ^a  

^a The University of Southern Mississippi   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR; INTERFERON;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE RESPONSE; EMBRYO; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INNATE IMMUNITY; MOUSE; MOUSE EMBRYONIC STEM CELL; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SOMATIC CELL; ANIMAL; CHIKUNGUNYA; CHIKUNGUNYA VIRUS; DBA MOUSE; EMBRYONIC STEM CELL; IMMUNITY; IMMUNOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY; RAW 264.7 CELL LINE; VIRUS INFECTION;

ANIMALS; CELL DIFFERENTIATION; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; EMBRYONIC STEM CELLS; IMMUNITY; INFLAMMATION; INTERFERONS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED DBA; NF-KAPPA B; RAW 264.7 CELLS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS DISEASES;

EID: 85014891235     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601068     Document Type: Article

References (53)

1. Wobus, A. M., and K. R. Boheler. 2005. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 85: 635-678.
2. Keller, G. 2005. Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev. 19: 1129-1155.
3. Tabar, V., and L. Studer. 2014. Pluripotent stem cells in regenerative medicine: challenges and recent progress. Nat. Rev. Genet. 15: 82-92.
4. Rajan, S., J. Ye, S. Bai, F. Huang, and Y. L. Guo. 2008. NF-kappaB, but not p38 MAP kinase, is required for TNF-a-induced expression of cell adhesion molecules in endothelial cells. J. Cell. Biochem. 105: 477-486.
5. Földes, G., A. Liu, R. Badiger, M. Paul-Clark, L. Moreno, Z. Lendvai, J. S. Wright, N. N. Ali, S. E. Harding, and J. A. Mitchell. 2010. Innate immunity in human embryonic stem cells: comparison with adult human endothelial cells. PLoS One 5: e10501.
6. Zampetaki, A., Q. Xiao, L. Zeng, Y. Hu, and Q. Xu. 2006. TLR4 expression in mouse embryonic stem cells and in stem cell-derived vascular cells is regulated by epigenetic modifications. Biochem. Biophys. Res. Commun. 347: 89-99.
7. Sidney, L. E., G. R. Kirkham, and L. D. Buttery. 2014. Comparison of osteogenic differentiation of embryonic stem cells and primary osteoblasts revealed by responses to IL-1b, TNF-a, and IFN-g. Stem Cells Dev. 23: 605-617.
8. Zampetaki, A., L. Zeng, Q. Xiao, A. Margariti, Y. Hu, and Q. Xu. 2007. Lacking cytokine production in ES cells and ES-cell-derived vascular cells stimulated by TNF-a is rescued by HDAC inhibitor trichostatin A. Am. J. Physiol. Cell Physiol. 293: C1226-C1238.
9. Glaser, D. E., R. M. Gower, N. E. Lauer, K. Tam, A. A. Blancas, A. J. Shih, S. I. Simon, and K. E. McCloskey. 2011. Functional characterization of embryonic stem cell-derived endothelial cells. J. Vasc. Res. 48: 415-428.
10. Guo, Y. L., G. G. Carmichael, R. Wang, X. Hong, D. Acharya, F. Huang, and F. Bai. 2015. Attenuated innate immunity in embryonic stem cells and its implications in developmental biology and regenerative medicine. Stem Cells 33: 3165-3173.
11. English, K., and K. J. Wood. 2011. Immunogenicity of embryonic stem cellderived progenitors after transplantation. Curr. Opin. Organ Transplant. 16: 90-95.
12. de Almeida, P. E., J. D. Ransohoff, A. Nahid, and J. C. Wu. 2013. Immunogenicity of pluripotent stem cells and their derivatives. Circ. Res. 112: 549-561.
13. Tan, Y., S. Ooi, and L. Wang. 2014. Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectives. Curr. Stem Cell Res. Ther. 9: 63-72.
14. Yu, J., R. Rossi, C. Hale, D. Goulding, and G. Dougan. 2009. Interaction of enteric bacterial pathogens with murine embryonic stem cells. [Published erratum appears in 2009 Infect. Immun. 77: 2239.] Infect. Immun. 77: 585-597.
15. Wash, R., S. Calabressi, S. Franz, S. J. Griffiths, D. Goulding, E.-P. Tan, H. Wise, P. Digard, J. Haas, S. Efstathiou, and P. Kellam. 2012. Permissive and restricted virus infection of murine embryonic stem cells. J. Gen. Virol. 93: 2118-2130.
16. Wang, R., C. Teng, J. Spangler, J. Wang, F. Huang, and Y.-L. Guo. 2014. Mouse embryonic stem cells have underdeveloped antiviral mechanisms that can be exploited for the development of mRNA-mediated gene expression strategy. Stem Cells Dev. 23: 594-604.
17. Wang, R., J. Wang, A. M. Paul, D. Acharya, F. Bai, F. Huang, and Y. L. Guo. 2013. Mouse embryonic stem cells are deficient in type I interferon expression in response to viral infections and double-stranded RNA. J. Biol. Chem. 288: 15926-15936.
18. Wang, R., J. Wang, D. Acharya, A. M. Paul, F. Bai, F. Huang, and Y. L. Guo. 2014. Antiviral responses in mouse embryonic stem cells: differential development of cellular mechanisms in type I interferon production and response. J. Biol. Chem. 289: 25186-25198.
19. Chen, L. L., L. Yang, and G. G. Carmichael. 2010. Molecular basis for an attenuated cytoplasmic dsRNA response in human embryonic stem cells. Cell Cycle 9: 3552-3564.
20. Chen, G. Y., S. M. Hwang, H. J. Su, C. Y. Kuo, W. Y. Luo, K. W. Lo, C. C. Huang, C. L. Chen, S. H. Yu, and Y. C. Hu. 2012. Defective antiviral responses of induced pluripotent stem cells to baculoviral vector transduction. J. Virol. 86: 8041-8049.
21. Samuel, C. E. 2001. Antiviral actions of interferons. Clin. Microbiol. Rev. 14: 778-809.
22. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
23. Yoneyama, M., M. Kikuchi, T. Natsukawa, N. Shinobu, T. Imaizumi, M. Miyagishi, K. Taira, S. Akira, and T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5: 730-737.
24. Kato, H., K. Takahasi, and T. Fujita. 2011. RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol. Rev. 243: 91-98.
25. Hayden, M. S., and S. Ghosh. 2012. NF-kB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev. 26: 203-234.
26. D'Angelo, W., D. Acharya, R. Wang, J. Wang, C. Gurung, B. Chen, F. Bai, and Y. L. Guo. 2016. Development of antiviral innate immunity during in vitro differentiation of mouse embryonic stem cells. Stem Cells Dev. 25: 648-659.
27. Guo, Y. L. 2017. Utilization of different anti-viral mechanisms by mammalian embryonic stem cells and differentiated cells. Immunol. Cell Biol. 95: 17-23.
28. Guo, Y. L., J. Ye, and F. Huang. 2007. p38a MAP kinase-deficient mouse embryonic stem cells can differentiate to endothelial cells, smooth muscle cells, and neurons. Dev. Dyn. 236: 3383-3392.
29. Pfaffl, M. W. 2001. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 29: e45.
30. Bai, F., T. Wang, U. Pal, F. Bao, L. H. Gould, and E. Fikrig. 2005. Use of RNA interference to prevent lethal murine West Nile virus infection. J. Infect. Dis. 191: 1148-1154.
31. Guo, Y. L., B. Kang, L. J. Yang, and J. R. Williamson. 1999. Tumor necrosis factor-alpha and ceramide induce cell death through different mechanisms in rat mesangial cells. Am. J. Physiol. 276: F390-F397.
32. Niwa, H., T. Burdon, I. Chambers, and A. Smith. 1998. Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev. 12: 2048-2060.
33. Pinney, D. F., and C. P. Emerson, Jr. 1989. 10T1/2 cells: an in vitro model for molecular genetic analysis of mesodermal determination and differentiation. Environ. Health Perspect. 80: 221-227.
34. Reznikoff, C. A., D. W. Brankow, and C. Heidelberger. 1973. Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res. 33: 3231-3238.
35. Ledebur, H. C., and T. P. Parks. 1995. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kB site and p65 homodimers. J. Biol. Chem. 270: 933-943.
36. Libermann, T. A., and D. Baltimore. 1990. Activation of interleukin-6 gene expression through the NF-kB transcription factor. Mol. Cell. Biol. 10: 2327-2334.
37. Sedger, L. M., and M. F. McDermott. 2014. TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants-past, present and future. Cytokine Growth Factor Rev. 25: 453-472.
38. Guo, Y. L., K. Baysal, B. Kang, L. J. Yang, and J. R. Williamson. 1998. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J. Biol. Chem. 273: 4027-4034.
39. Acharya, D., A. M. Paul, J. F. Anderson, F. Huang, and F. Bai. 2015. Loss of glycosaminoglycan receptor binding after mosquito cell passage reduces chikungunya virus infectivity. PLoS Negl. Trop. Dis. 9: e0004139.
40. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 12: 141-179.
41. Lee, S. H., B. Hong, A. Sharabi, X. F. Huang, and S. Y. Chen. 2009. Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products. Stem Cells 27: 1604-1615.
42. Taylor, T., Y. J. Kim, X. Ou, W. Derbigny, and H. E. Broxmeyer. 2010. Toll-like receptor 2 mediates proliferation, survival, NF-kappaB translocation, and cytokine mRNA expression in LIF-maintained mouse embryonic stem cells. Stem Cells Dev. 19: 1333-1341.
43. Wuu, Y. D., S. Pampfer, I. Vanderheyden, K. H. Lee, and R. De Hertogh. 1998. Impact of tumor necrosis factor alpha on mouse embryonic stem cells. Biol. Reprod. 58: 1416-1424.
44. Torres, J., and F. M. Watt. 2008. Nanog maintains pluripotency of mouse embryonic stem cells by inhibiting NFkappaB and cooperating with Stat3. Nat. Cell Biol. 10: 194-201.
45. Armstrong, L., O. Hughes, S. Yung, L. Hyslop, R. Stewart, I. Wappler, H. Peters, T. Walter, P. Stojkovic, J. Evans, et al. 2006. The role of PI3K/AKT, MAPK/ ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum. Mol. Genet. 15: 1894-1913.
46. Kim, Y. E., H. B. Kang, J. A. Park, K. H. Nam, H. J. Kwon, and Y. Lee. 2008. Upregulation of NF-kappaB upon differentiation of mouse embryonic stem cells. BMB Rep. 41: 705-709.
47. Kang, H. B., Y. E. Kim, H. J. Kwon, D. E. Sok, and Y. Lee. 2007. Enhancement of NF-kappaB expression and activity upon differentiation of human embryonic stem cell line SNUhES3. Stem Cells Dev. 16: 615-623.
48. Luningschrör, P., B. Stöcker, B. Kaltschmidt, and C. Kaltschmidt. 2012. miR-290 cluster modulates pluripotency by repressing canonical NF-kB signaling. Stem Cells 30: 655-664.
49. Kurt-Jones, E. A., F. Sandor, Y. Ortiz, G. N. Bowen, S. L. Counter, T. C. Wang, and R. W. Finberg. 2004. Use of murine embryonic fibroblasts to define Toll-like receptor activation and specificity. J. Endotoxin Res. 10: 419-424.
50. Sacre, S. M., A. M. C. Lundberg, E. Andreakos, C. Taylor, M. Feldmann, and B. M. Foxwell. 2007. Selective use of TRAM in lipopolysaccharide (LPS) and lipoteichoic acid (LTA) induced NF-kappaB activation and cytokine production in primary human cells: TRAM is an adaptor for LPS and LTA signaling. J. Immunol. 178: 2148-2154.
51. Hertzog, P. J., S. Y. Hwang, and I. Kola. 1994. Role of interferons in the regulation of cell proliferation, differentiation, and development. Mol. Reprod. Dev. 39: 226-232.
52. Levy, O. 2007. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat. Rev. Immunol. 7: 379-390.
53. Pare, J. M., and C. S. Sullivan. 2014. Distinct antiviral responses in pluripotent versus differentiated cells. PLoS Pathog. 10: e1003865.